Literature DB >> 603847

Long-term treatment of severe hypertension with minoxidil.

T Nawar, L Nolin, G E Plante, C Caron, P Montambault.   

Abstract

Minoxidil, a new potent hypotensive agent, was used as the primary antihypertensive agent in 11 patients--10 men and 1 woman aged 35 to 54 years with severe hypertension that was refractory to treatment with maximal (or maximally tolerated) doses of conventional antihypertensive agents. Six patients had severely impaired renal function and three of them were undergoing long-term hemodialysis. The patients were given 2.5 to 40 mg/d of minoxidil for periods of 2 to 29 months. All except one who was almost anuric received propranolol and diuretics. Blood pressure was controlled satisfactorily in all patients. In two patients the hypertension became partially resistant after 1 year of treatment. The main side effects were sodium retention, tachycardia and hirsutism. Renal function remained stable or improved and hemodialysis was discontinued in two patients. Minoxidil is a remarkably potent hypotensive with relatively few side effects and seems particularly advantageous in patients with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 603847      PMCID: PMC1880293     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  12 in total

1.  Treatment of severe hypertension with minoxidil.

Authors:  Y M Traub; D P Redmond; J B Rosenfeld; R H McDonald; A P Shapiro
Journal:  Isr J Med Sci       Date:  1975-10

Review 2.  Vasodilator drugs in the treatment of hypertension.

Authors:  J Koch-Weser
Journal:  Arch Intern Med       Date:  1974-06

3.  Re-examination of the hemodynamics of hypertension.

Authors:  E D Frohlich; R C Tarazi; H P Dustan
Journal:  Am J Med Sci       Date:  1969-01       Impact factor: 2.378

4.  Minoxidil--an alternative to nephrectomy for refractory hypertension.

Authors:  W A Pettinger; H C Mitchell
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

5.  Vasodilation for vasopastic hypertension.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

6.  Pharmacologic properties of minoxidil: a new hypotensive agent.

Authors:  D W DuCharme; W A Freyburger; B E Graham; R G Carlson
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

7.  Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugs.

Authors:  C J Limas; E D Freis
Journal:  Am J Cardiol       Date:  1973-03       Impact factor: 2.778

8.  Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide.

Authors:  R L Wilburn; A Blaufuss; C M Bennet
Journal:  Circulation       Date:  1975-10       Impact factor: 29.690

9.  Long-term effects of minoxidil in the treatment of malignant hypertension in chronic renal failure.

Authors:  R E Mutterperl; F B Diamond; D T Lowenthal
Journal:  J Clin Pharmacol       Date:  1976-10       Impact factor: 3.126

10.  Minoxidil therapy in children with severe hypertension.

Authors:  A J Pennisi; M Takahashi; B H Bernstein; B H Singsen; C Uittenbogaart; R B Ettenger; M H Malekzadeh; V Hanson; R N Fine
Journal:  J Pediatr       Date:  1977-05       Impact factor: 4.406

View more
  4 in total

Review 1.  Minoxidil: a review of its pharmacological properties and therapeutic use.

Authors:  V M Campese
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 2.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

Review 3.  Treatment resistant hypertension--investigation and conservative management.

Authors:  Franz Weber; Manfred Anlauf
Journal:  Dtsch Arztebl Int       Date:  2014-06-20       Impact factor: 5.594

4.  Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.

Authors:  Heiko M Mundt; Matthias Matenaer; Alexander Lammert; Uwe Göttmann; Bernhard K Krämer; Rainer Birck; Urs Benck
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-01       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.